Loading...

Follow Mesothelioma Help Cancer Organization: Support.. on Feedspot

Continue with Google
Continue with Facebook
or

Valid

It has been over two years since MesotheliomaHelp reported on the start of a clinical trial that used a combination of immunotherapy drugs to treat lung cancer. The trial was designed to determine whether the two drugs would work better than one in the treatment of cancer patients. Now, researchers say early results of the trial show the pair of drugs are “surprisingly effective” at controlling the progression of lung cancer. Immunologist John Wrangle, M.D. and his colleague Mark Rubinstein, Ph.D., both from the Hollins Cancer Center at The Medical College of South Carolina (MUSC), are so excited with the […]

The post Two-Drug Combination Found Effective in Lung Cancer May Increase Survival in Mesothelioma Patients appeared first on MesotheliomaHelp.org.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The way that malignant mesothelioma will be some day be cured is through research. And, the way to get that cure to patients starts with clinical trials. Progress takes time, but participation in clinical trials by people who have been diagnosed with malignant mesothelioma is essential. Clinical trials are where new therapies and new medications are scientifically tested for use. Enrollment in clinical trials is encouraged for everyone. If you personally do not benefit from the clinical trial, someone you love, or a neighbor, or a friend could benefit in the future.  Currently, less than five percent of patients with […]

The post Mesothelioma Nurse Stresses the Importance of Clinical Trials appeared first on MesotheliomaHelp.org.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The key to increased life expectancy when battling lung cancer, and other extremely aggressive cancers such as mesothelioma, is early detection. Unfortunately, while there are standard screening tests and guidelines for breast cancer, colon, and prostate cancer, lung cancer screening tests are limited to high risk patients, defined as life-long heavy smokers. Now, researchers have developed a personalized lung cancer screening decision tool which incorporates past asbestos exposure as a criteria to guide individuals and physicians in determining their lung cancer screening options. Researchers from the University of Michigan have unveiled a lung cancer screening Q&A tool that can be […]

The post “Lung Decision Precision” Screening Tool May Lead to Early Detection of Mesothelioma appeared first on MesotheliomaHelp.org.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Immunotherapy is still a relatively new treatment for mesothelioma and other cancers, and researchers continue to work to increase its effectiveness. In the latest news involving the immunotherapy drug Keytruda, shown effective in some mesothelioma patients, the maker of the drug is joining efforts with a company that develops companion diagnostics for immuno-oncology drugs. The collaboration could bring personalized care one step closer to mesothelioma patients. Last month, Foundation Medicine announced that they signed a deal with Merck that will use the company’s FoundationOne CDx™ genomic profiling assay to create a pan-cancer companion diagnostic to measure microsatellite instability (MSI), tumor […]

The post Partnership Turns Focus to Targeted Therapy for Mesothelioma Patients appeared first on MesotheliomaHelp.org.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The key to increasing  survival for mesothelioma patients is to kill the cancer cells before they can spread to other organs. Treatment options, including surgery, chemotherapy and radiation, all contribute to a patient’s survival, but many times the prognosis remains unchanged. Now, one company has turned to experimenting with delivering electromagnetic waves to the chest of pleural mesothelioma patients and reports improvements in overall survival when combined with chemotherapy. Novocure, a UK-based medical device company that develops and markets Tumor Treating Fields delivery systems,  developed the novel devices as an alternative way to destroy tumor cells while sparing healthy tissue. […]

The post Combination of Electric Fields and Chemotherapy May Be A New Treatment Option for Pleural Mesothelioma Patients appeared first on MesotheliomaHelp.org.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview